Andrew Callos - Mar 14, 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
EVP, Chief Commercial Officer
Signature
/s/ John Faurescu, attorney-in-fact for Mr. Callos
Stock symbol
CYTK
Transactions as of
Mar 14, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 07:02 PM
Previous filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $0 +16.9K +36.09% $0.00 63.9K Mar 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Award $0 +18.3K $0.00 18.3K Mar 14, 2024 Common Stock 18.3K $63.75 Direct F2
transaction CYTK Incentive Stock Option (Right to Buy) Award $0 +1.22K $0.00 1.22K Mar 14, 2024 Common Stock 1.22K $63.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
F2 This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028.